Fuso Pharmaceutical Industries,Ltd.

4538 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥2,182.00
-1.22%
Delayed · cached 15 min

Fair value analysis

4538
Fuso Pharmaceutical Industries,Ltd.
Pharmaceuticals›Pharmaceutical
¥2,182.00
Close used for this calculation
¥4,296.55Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
52/100
Profitability11/25
Returns15/25
Balance Sheet1/25
Efficiency25/25
Growth16/25
Good
Quality radar
52Prof.11/25Ret.15/25Eff.25/25B.Sht1/25Growth16/25

Consensus fair value

¥4,296.55
Below FV
▲ +96.9% against the close used
Model range ¥1,863.83 – ¥5,331.66
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥1,863.83Fair value¥4,296.55Bull¥5,331.66
FairClose
52-week traded range
52W low ¥2,003.0052W high ¥2,518.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Fuso Pharmaceutical Industries,Ltd. closed at ¥2,182.00, 49.2% below the consensus fair value of ¥4,296.55 drawn from 9 valuation models.

Financial DNA score 52/100 — Good. P/E of 9.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
¥4,393.54
+101.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=7.9%, r=10%, tg=3%, n=10yr
Graham Number
¥4,671.93
+114.1%
√(22.5 × EPS × BVPS)
EPS=235.63, BVPS=4116.98
P/E Fair Value
¥4,712.60
+116.0%
EPS × 20x (sector P/E)
EPS=235.63, Sector P/E=20x
Peter Lynch (PEG)
¥1,863.83
-14.6%
EPS × Growth% (PEG = 1 is fair)
EPS=235.63, g=7.9%
EV/EBITDA
¥5,331.66
+144.3%
(EBITDA × 14x − Net Debt) ÷ Shares
EBITDA=5.26B
Dividend Discount (DDM)
¥4,641.60
+112.7%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=89.9, r=10%, g=7.9%
Book Value (P/B)
¥2,429.02
+11.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=4116.98, ROE=5.9%, g=6%, r=10%
Reverse DCF
¥2,182.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -3.4% | Historical: 7.9%
Margin of Safety
¥3,444.52
+57.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=4592.69, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.